Kelly MacDonald, Chief Accounting Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 3,561 shares at $11.75 ($42K) on 2020-11-11, disclosed to the SEC on 2020-11-13.
Scheduled sale ($42k) by Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IRWD | SELL | 2020-10-13 | $238K | — | Filing → |
| IRWD | SELL | 2020-08-19 | $6K | — | Filing → |
| IRWD | SELL | 2020-05-13 | $12K | — | Filing → |